Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer.

Briefings in Bioinformatics
Mingyi JuLin Zhao

Abstract

NLRP3 inflammasome was introduced as a double-edged sword in tumorigenesis and influenced immunotherapy response by modulating host immunity. However, a systematic assessment of the NLRP3-inflammasome-related genes across human cancers is lacking, and the predictive role of NLRP3 inflammasome in cancer immunotherapy (CIT) response remains unexplored. Thus, in this study, we performed a pan-cancer analysis of NLRP3-inflammasome-related genes across 24 human cancers. Out of these 24 cancers, 15 cancers had significantly different expression of NLRP3-inflammasome-related genes between normal and tumor samples. Meanwhile, Cox regression analysis showed that the NLRP3 inflammasome score could be served as an independent prognostic factor in skin cutaneous melanoma. Further analysis indicated that NLRP3 inflammasome may influence tumor immunity mainly by mediating tumor-infiltrating lymphocytes and macrophages, and the effect of NLRP3 inflammasome on immunity is diverse across tumor types in tumor microenvironment. We also found that the NLRP3 inflammasome score could be a stronger predictor for immune signatures compared with tumor mutation burden (TMB) and glycolytic activity, which have been reported as immune predictors. Furtherm...Continue Reading

References

Aug 3, 2002·Oncogene·Melanie Ehrlich
Apr 14, 2010·The Journal of Experimental Medicine·Irving C AllenJenny P-Y Ting
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandra S McAllister, Robert A Weinberg
Jul 5, 2011·Cancer Research·Magali TermeLaurence Zitvogel
Apr 25, 2012·Pigment Cell & Melanoma Research·Deepti VermaPeter Söderkvist
Jan 18, 2013·BMC Bioinformatics·Sonja HänzelmannJustin Guinney
Oct 12, 2013·Nature Communications·Kosuke YoshiharaRoel G W Verhaak
Oct 30, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Qing WeiLihui Han
Feb 20, 2015·Molecular Cancer Therapeutics·Sandip Pravin Patel, Razelle Kurzrock
Apr 17, 2015·Immunological Reviews·Si Ming Man, Thirumala-Devi Kanneganti
Nov 11, 2015·BMC Cancer·Maarten P G MassinkHanne Meijers-Heijboer
Jan 18, 2017·Cancer Immunology Research·Rajendra KarkiThirumala-Devi Kanneganti
Apr 27, 2017·The Journal of Experimental Medicine·Donnele DaleyGeorge Miller
Aug 25, 2017·Molecular Cancer Therapeutics·Aaron M GoodmanRazelle Kurzrock
Sep 4, 2017·Journal of Experimental & Clinical Cancer Research : CR·Cong-Fa HuangZhi-Jun Sun
Nov 19, 2017·Proceedings of the National Academy of Sciences of the United States of America·Cornelia VoigtSebastian Kobold
Feb 8, 2018·Translational Oncology·Zhixian LiuXiaosheng Wang
Mar 24, 2018·Science·Antoni Ribas, Jedd D Wolchok
Apr 10, 2018·Immunity·Vésteinn ThorssonIlya Shmulevich
Nov 6, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T A ChanS Peters
Nov 19, 2018·Molecular Cancer·Maryam MoossaviAmirhossein Sahebkar
Jan 23, 2019·Immunology·Sarang Tartey, Thirumala-Devi Kanneganti
Mar 8, 2019·Nature Reviews. Cancer·Rajendra Karki, Thirumala-Devi Kanneganti
Jan 14, 2020·Expert Review of Clinical Immunology·Mahdi GouravaniNima Rezaei
Jan 16, 2020·Immunity·Priti S Hegde, Daniel S Chen
Feb 1, 2020·Science·Suzanne L TopalianDrew M Pardoll
Feb 6, 2020·The Journal of Clinical Investigation·Balamayoora TheivanthiranBrent A Hanks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.